Please login to the form below

Not currently logged in


This page shows the latest Acino news and features for those working in and with pharma, biotech and healthcare.

Oncology bias in pharma deals

Regorafenib is in phase III. 160. Cephalon/Acino. Regional business acquisition. Generics.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Deal Watch table for October 2013 Deal Watch table for October 2013

    440. Acino / Avista Capital and Nordic Capital. Acquisition. Portfolio of drug delivery products (marketed).

  • Pharma deals during October 2013 Pharma deals during October 2013

    The other major deal featuring PE is the acquisition of Acino by Avista Capital Partners and Nordic Capital for $439m. ... share. The sale has been strongly supported by the Acino Board, notably the stock had fallen by 62 per cent over the last five years

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....